NMPA

Explore the landscape of NMPA in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on NMPA to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Eli Lilly's Omvoh Delivers First One‑Year Phase 3 Readout in Pediatric Ulcerative Colitis – 50 % Clinical Remission at Week 52 in SHINE‑2
CompanyDrug

Eli Lilly’s Omvoh Delivers First One‑Year Phase 3 Readout in Pediatric Ulcerative Colitis – 50 % Clinical Remission at Week 52 in SHINE‑2

Eli Lilly and Company (NYSE: LLY) announced positive late‑breaking one‑year results from the Phase 3 SHINE‑2 study of Omvoh (mirikizumab‑mrkz) in pediatric patients ages 6 to 17 with moderately to…

Insilico Medicine Earns Milestone Payment from Servier – First Oncology Program Hits Early‑Stage Drug Discovery Mark on Pharma.AI Platform

Insilico Medicine Earns Milestone Payment from Servier – First Oncology Program Hits Early‑Stage Drug Discovery Mark on Pharma.AI Platform

NMPA Publishes 110th Batch of Chemical Generic Drug Reference Listed Drug Catalog – 28 New Specifications Added

NMPA Publishes 110th Batch of Chemical Generic Drug Reference Listed Drug Catalog – 28 New Specifications Added

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Policy / Regulatory

China’s NMPA Releases 60th Batch of Reference Drugs for Generic Quality Evaluation

CompanyDeals

Insight Lifetech Raises Funds for Cardiovascular Solutions Expansion

CompanyMedical Device

China’s First Proton Therapy System Approved by NMPA

DrugPolicy / Regulatory

NMPA Releases 58th Batch of Reference Drugs for Generic Quality Consistency Evaluation

CompanyPolicy / Regulatory

NMPA Issues Guidelines on Medical Device Grading Administration

Policy / Regulatory

NMPA Designates Shijiazhuang Airport as Drug Import Port for Narcotics, Psychotropics

Policy / Regulatory

NMPA Releases 57th Batch of Reference Drugs for Generic Consistency Evaluation

Policy / Regulatory

NMPA Reclassifies Omeprazole Tablets from Prescription to OTC Status

Show More